Literature DB >> 7630041

A study on dilazep: II. Dilazep attenuates lysophosphatidylcholine-induced mechanical and metabolic derangements in the isolated, working rat heart.

A N Hoque1, N Hoque, H Hashizume, Y Abiko.   

Abstract

The effects of dilazep, d-propranolol and lidocaine on the mechanical and metabolic changes induced by lysophosphatidylcholine (LPC) were studied in isolated, perfused working rat heart. After a stabilization period, the heart was perfused for 5 min with LPC (10 microM) alone, LPC plus dilazep (5, 10 or 20 microM), LPC plus d-propranolol (30 or 50 microM) or LPC plus lidocaine (30 or 100 microM) and then perfused with normal Krebs-Henseleit bicarbonate (KHB) buffer for a further 20 min. Perfusion with LPC for 5 min followed by KHB for 20 min irreversibly decreased cardiac mechanical function, decreased the tissue levels of adenosine triphosphate and creatine phosphate significantly, and increased the tissue levels of lactate and free fatty acids including arachidonic acid. Dilazep or d-propranolol significantly attenuated the mechanical and metabolic changes induced by LPC, but lidocaine did not. These results indicate that the exogenous LPC causes ischemia-like changes, suggesting that LPC is one of the important factors in producing ischemia-reperfusion derangements in terms of mechanical and metabolic functions, and that both dilazep and d-propranolol can prevent the LPC-induced myocardial damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7630041     DOI: 10.1254/jjp.67.233

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  2 in total

1.  Cell membrane-derived lysophosphatidylcholine activates cardiac ryanodine receptor channels.

Authors:  Yuki Nakamura; Midori Yasukochi; Sei Kobayashi; Kiyoko Uehara; Akira Honda; Ryuji Inoue; Issei Imanaga; Akira Uehara
Journal:  Pflugers Arch       Date:  2006-10-07       Impact factor: 3.657

2.  Effects of beta-adrenoceptor antagonists on Ca(2+)-overload induced by lysophosphatidylcholine in rat isolated cardiomyocytes.

Authors:  M Chen; H Hashizume; Y Abiko
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.